1,043
Views
26
CrossRef citations to date
0
Altmetric
Author's View

Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy

, , , &
Article: e27663 | Received 25 Dec 2013, Accepted 25 Dec 2013, Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Zinat Yazdani, Zahra Mousavi, Alireza Moradabadi & Gholamhossein Hassanshahi. (2020) Significance of CXCL12/CXCR4 Ligand/Receptor Axis in Various Aspects of Acute Myeloid Leukemia. Cancer Management and Research 12, pages 2155-2165.
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy. OncoImmunology 5:6.
Read now
Elisa E. Baracco, Federico Pietrocola, Aitziber Buqué, Norma Bloy, Laura Senovilla, Laurence Zitvogel, Erika Vacchelli & Guido Kroemer. (2016) Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. OncoImmunology 5:6.
Read now
Sabrina Forveille, Heng Zhou, Allan Sauvat, Lucillia Bezu, Kevin Müller, Peng Liu, Laurence Zitvogel, Gérard Pierron, Øystein Rekdal, Oliver Kepp & Guido Kroemer. (2015) The oncolytic peptide LTX-315 triggers necrotic cell death. Cell Cycle 14:21, pages 3506-3512.
Read now
Jonathan Pol, Norma Bloy, Aitziber Buqué, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Peptide-based anticancer vaccines. OncoImmunology 4:4.
Read now
Jonathan Pol, Erika Vacchelli, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. OncoImmunology 4:4.
Read now

Articles from other publishers (20)

Alireza Kashefizadeh & Hossein Kazemizadeh. (2022) Immunogenic cell death (ICD)-inducers in non-small-cell lung carcinoma (NSCLC): current knowledge and future perspective. Clinical and Translational Oncology 25:2, pages 316-322.
Crossref
Dandan Sheng, Wei Ma, Rui Zhang, Lei Zhou, Qiaodan Deng, Juchuanli Tu, Weilong Chen, Fuchuang Zhang, Nailong Gao, Mengxue Dong, Dong Wang, Fengkai Li, Yin Liu, Xueyan He, Shengzhong Duan, Lixing Zhang, Tong Liu & Suling Liu. (2022) Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization. Journal for ImmunoTherapy of Cancer 10:5, pages e003793.
Crossref
Pedro Bule, Sandra Isabel Aguiar, Frederico Aires-Da-Silva & Joana Nunes Ribeiro Dias. (2021) Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. International Journal of Molecular Sciences 22:18, pages 9804.
Crossref
Bahar Yazdani, Hussein Anani, iman baluchi, Behjat Kalantary Khandany & Gholamhossein Hassanshahi. (2021) Effect of Chemotherapy on Serum Level of CCL2 in Acute Myeloid Leukemia Patients with Monocytic Differentiation. Medical Laboratory Journal 15:4, pages 9-14.
Crossref
Zinat Yazdani, Iman Baluchi, Behjat Kalantary Khandany & gholamhosein hassanshahi. (2021) Effect of Chemotherapy on CXCL1 and CXCL10 Levels in Acute Myeloid Leukemia Patients with M4/M5 Subtype. Medical Laboratory Journal 15:2, pages 5-10.
Crossref
Jie Zhou, Zhiman Xie, Ping Cui, Qisi Su, Yu Zhang, Lijia Luo, Zhuoxin Li, Li Ye, Hao Liang & Jiegang Huang. (2020) SLC1A1 , SLC16A9 , and CNTN3 Are Potential Biomarkers for the Occurrence of Colorectal Cancer . BioMed Research International 2020, pages 1-12.
Crossref
Jie Li, Qin Liu, Xuan Huang, Yurui Cai, Li Song, Qianrong Xie, Fuchuan Liu, Xiaochun Chen, Peng Xu, Fanwei Zeng, Yanpeng Chu & Fanxin Zeng. (2020) Transcriptional Profiling Reveals the Regulatory Role of CXCL8 in Promoting Colorectal Cancer. Frontiers in Genetics 10.
Crossref
Sanjeev Kumar Sagwal, Gabriella Pasqual-Melo, Yana Bodnar, Rajesh Kumar Gandhirajan & Sander Bekeschus. (2018) Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16. Cell Death & Disease 9:12.
Crossref
Daniela Lulli, Maria Carbone & Saveria Pastore. (2017) The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes. International Journal of Molecular Sciences 18:10, pages 2227.
Crossref
Federica Liotti, Maria De Pizzol, Marcello Allegretti, Nella Prevete & Rosa Marina Melillo. (2017) Multiple anti-tumor effects of Reparixin on thyroid cancer. Oncotarget 8:22, pages 35946-35961.
Crossref
R.A. Lacalle, R. Blanco, L. Carmona-Rodríguez, A. Martín-Leal, E. Mira & S. Mañes. 2017. 181 244 .
C Botta, M T Di Martino, D Ciliberto, M Cucè, P Correale, M Rossi, P Tagliaferri & P Tassone. (2016) A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival. Blood Cancer Journal 6:12, pages e511-e511.
Crossref
Shiva Marthandan, Uwe Menzel, Steffen Priebe, Marco Groth, Reinhard Guthke, Matthias Platzer, Peter Hemmerich, Christoph Kaether & Stephan Diekmann. (2016) Conserved genes and pathways in primary human fibroblast strains undergoing replicative and radiation induced senescence. Biological Research 49:1.
Crossref
Daniela Lulli, Maria Luigia Carbone & Saveria Pastore. (2016) Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin. Oncotarget 7:30, pages 47777-47793.
Crossref
JIE CAI, MEI WANG, MENGCHU ZHU, QIANG ZHANG, XU ZHANG, YONGMIN YAN, HUI QIAN & WENRONG XU. (2016) N-methyl-N-nitro-N′-nitrosoguanidine induces the expression of CCR2 in human gastric epithelial cells promoting CCL2-mediated migration. Molecular Medicine Reports 13:2, pages 1083-1090.
Crossref
Abbas K. Samadi, Alan Bilsland, Alexandros G. Georgakilas, Amedeo Amedei, Amr Amin, Anupam Bishayee, Asfar S. Azmi, Bal L. Lokeshwar, Brendan Grue, Carolina Panis, Chandra S. Boosani, Deepak Poudyal, Diana M. Stafforini, Dipita Bhakta, Elena Niccolai, Gunjan Guha, H.P. Vasantha Rupasinghe, Hiromasa Fujii, Kanya Honoki, Kapil Mehta, Katia Aquilano, Leroy Lowe, Lorne J. Hofseth, Luigi Ricciardiello, Maria Rosa Ciriolo, Neetu Singh, Richard L. Whelan, Rupesh Chaturvedi, S. Salman Ashraf, H.M.C. Shantha Kumara, Somaira Nowsheen, Sulma I. Mohammed, W. Nicol Keith, William G. Helferich & Xujuan Yang. (2015) A multi-targeted approach to suppress tumor-promoting inflammation. Seminars in Cancer Biology 35, pages S151-S184.
Crossref
Min Hu, Kai Li, Ninu Maskey, Zhigao Xu, Fang Yu, ChunWei Peng, Yan Li & Guifang Yang. (2015) Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer. Human Pathology 46:12, pages 1872-1880.
Crossref
David A. Reardon, Mark R. Gilbert, Wolfgang Wick & Linda Liau. (2015) Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy. Neuro-Oncology 17:suppl 7, pages vii32-vii40.
Crossref
Hongxin Niu, Xiangshan Yang, Zhongfa Xu, Tong Du & Ruogu Wang. (2014) Cell surface nucleolin interacts with CXCR4 receptor via the 212 c-terminal portion. Tumor Biology 36:2, pages 1099-1104.
Crossref
Maria Vela, Mariana Aris, Mercedes Llorente, Jose A. Garcia-Sanz & Leonor Kremer. (2015) Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges. Frontiers in Immunology 6.
Crossref